
Healthcare price transparency data is the public, machine-readable pricing information that hospitals and payers must publish under the Hospital Price Transparency rule (January 2021) and the Transparency in Coverage rule (July 2022).
For market intelligence, payer-published data is often the most useful because it shows negotiated rates across CPT, HCPCS, DRG, and other billing codes.
This data helps answer questions like:
Used well, negotiated rates data supports benchmarking, network strategy, contract negotiations, and broader market intelligence.
Two federal rules created today’s transparency landscape: Hospital Price Transparency (January 2021) and Transparency in Coverage (July 2022). Together, they pushed pricing data into the open in machine-readable formats.
This is not just a compliance story. As enforcement and data quality improve, the strategic value of benchmarking and market comparison grows.
The policy direction is accelerating. On June 25, 2026, the House Energy and Commerce Health Subcommittee advanced a package of healthcare bills to the full committee, including several focused squarely on price transparency, payer accountability, Medicare Advantage data, and consumer access to cost information.
The package includes H.R. 9393 (the Lower Costs, More Transparency Act of 2026), H.R. 9397 (the Premium Transparency Act), H.R. 9390 (the Prices on the Wall Act of 2026), and H.R. 9392 (the Medicare Advantage Cost Transparency Act). Together, they signal that lawmakers want more healthcare pricing information to be visible, standardized, and available before decisions are made, extending beyond hospital price-posting into premium data, Medicare Advantage cost and encounter data, and prior authorization accountability.
For anyone working with price transparency data today, that matters: the volume and variety of public pricing data is set to grow, which raises the stakes on turning disclosure into usable market intelligence rather than just more files to store.
The regulations created access to information, but they did not make the market instantly transparent.
Machine-readable files can be enormous. A single analysis may require querying billions of rows of payer-published rates.
In our latest Gigasheet webinar (video above), a drill-down into Missouri payer data queried roughly four billion rates to isolate the relevant records for a specific provider, market, payer, and CPT code.
A payer may publish data that technically passes a schema but is still difficult to interpret. Compliance does not guarantee usability.
That is the difference between information and intelligence.
Hospital and payer transparency files answer different questions. Claims data answers a third question: what was actually paid.
Best practice: Use payer MRFs as the primary benchmarking input, then validate with claims and remits where available.
The strongest analysis combines payer rates, hospital rates, Medicare benchmarks, provider taxonomy, geography, plan details, and internal utilization.
Good analysis starts with a business question, not a data dump.
Once the question is clear, the workflow becomes disciplined.
Most organizations should begin with the codes that matter financially. For providers, that often means the highest-volume CPTs, HCPCS codes, or DRGs. Examples might include:
The goal is not to analyze every code at once. It is to find the codes where rate variation and volume combine into meaningful financial impact.
Broad averages are easy to dismiss. A strong benchmark uses a defensible comparison cohort.
That may mean filtering by:
A family medicine provider should not be benchmarked against every provider in the state. An orthopedic group should not compare its commercial rates against an unfiltered pile of facility, professional, and irrelevant records. The sharper the cohort, the more credible the benchmark.
Rate comparisons are more useful when the data is normalized.
One common approach is to express rates as a percentage of Medicare. If Medicare pays $100 for a service and a commercial payer pays $145, the commercial rate is 145% of Medicare. That makes comparisons easier across codes, payers, and markets.
Normalization can also include removing outliers, separating places of service, deduplicating overlapping records, and identifying rates that are not relevant to the provider or procedure being studied.
Aggregate views are useful, but they can hide important nuance.
In the Gigasheet webinar example, a family medicine provider in the Springfield, Missouri area appeared to have multiple rates for CPT 99214, a common office visit code. At first glance, that looks confusing. Why would one provider have many different rates for one code?
The answer is that multiple things can be true at once.
The rate may vary by payer. It may vary by plan. It may vary by place of service. It may vary because the provider works with multiple organizations or facilities. It may also reflect how the payer published provider identifiers such as NPI or TIN.
In one example, rates differed for in-office versus hospital-related settings. In another, plan information explained why the same payer appeared to have more than one rate. Both rates could be valid, but they answer different questions.
This is why row-level inspection matters. A summary can tell you that a rate is high or low. The raw details help explain why.
Consider a provider organization preparing for payer negotiations.
The team wants to know whether its family medicine rates are competitive in a specific Missouri market. It starts with CPT 99214, then expands to a small basket of office visit codes.
The analysis asks:
In the Gigasheet webinar visuals (see video above), this approach made rate position obvious in a single view.
That kind of clarity changes the negotiation posture. Instead of “Our costs went up,” the provider can show the benchmark, the peer group, and the financial impact.
Healthcare price transparency data is not only useful for provider contract negotiations.
Benefits consultants, brokers, TPAs, and self-funded employers can use payer price transparency data to evaluate whether an employer plan is actually receiving competitive rates in a market.
For example, an employer might compare its plan’s orthopedic rates against broader commercial market rates for total knee replacement. The analysis could show:
That matters because self-funded plans are often sold on the promise of strong network economics. Price transparency data gives employers and their advisors a way to test that claim with actual market evidence.
The practical implications are significant.
Healthcare price transparency data is the public, machine-readable pricing information that hospitals and payers publish under federal transparency rules, including negotiated rates for covered services.
Hospital transparency focuses on a hospital’s charges and negotiated charges, while payer transparency (TiC) publishes negotiated rates across providers, plans, and geographies.
On June 25, 2026, the House Energy and Commerce Health Subcommittee advanced a package of bills including the Lower Costs, More Transparency Act of 2026 (H.R. 9393), the Premium Transparency Act (H.R. 9397), the Prices on the Wall Act of 2026 (H.R. 9390), and the Medicare Advantage Cost Transparency Act (H.R. 9392). Together, they aim to expand price transparency, payer accountability, and consumer access to cost information beyond current hospital and payer disclosure rules.
Providers use negotiated rates data to benchmark against peers, find under-market contracts, and build evidence for payer negotiations.
The files are large and inconsistent, so reliable analysis usually requires parsing, deduplication, normalization, and filtering out implausible records.
No—negotiated rates show contracted amounts, while claims and remits show what was actually billed and paid.
Normalize commercial rates to a common reference (often Medicare), filter to a defensible peer group, and compare position by high-impact codes.
Zombie rates are implausible provider-procedure rate entries that can distort benchmarks if they are not filtered out during cleaning.